Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2022-06-16 00:00:00 ET · period of report 2022-06-15 · accession 0001837830-22-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-16 | 2022-06-15 | NMTC | McClurg Ronald W. | CFO | P - Purchase | $1.02 | +10.0K | 67.0K | +18% | +$10.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-15 | P | A | 10,000 | $1.02 | 67,000 | D | — | — | (F1) The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $0.9278 to $1.0599 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. |